The Board remands the claim for essential thrombocytosis to obtain an addendum opinion addressing all toxic exposure risks, including herbicides.
The deciding factor: The February 2024 VA examiner's opinion was inadequate as it did not address all of the Veteran's TERA exposures.
- Claimed conditions
- essential thrombocytosis
- How they argued it
- Not specified
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- June 12, 2025
- Citation
- A25052023
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.